These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15689292

  • 21. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [Abstract] [Full Text] [Related]

  • 22. Case series of rosiglitazone used during the first trimester of pregnancy.
    Haddad GF, Jodicke C, Thomas MA, Williams DB, Aubuchon M.
    Reprod Toxicol; 2008 Oct; 26(2):183-4. PubMed ID: 18762242
    [Abstract] [Full Text] [Related]

  • 23. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF, Nilas L, Nørgaard K, Madsbad S.
    Ugeskr Laeger; 2005 Aug 22; 167(34):3147-51. PubMed ID: 16117910
    [Abstract] [Full Text] [Related]

  • 24. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
    Nawrocka J, Starczewski A.
    Gynecol Endocrinol; 2007 Apr 22; 23(4):231-7. PubMed ID: 17505944
    [Abstract] [Full Text] [Related]

  • 25. Insulin sensitizers in polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Front Horm Res; 2013 Apr 22; 40():83-102. PubMed ID: 24002407
    [Abstract] [Full Text] [Related]

  • 26. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
    Fertil Steril; 2006 May 22; 85(5):1448-51. PubMed ID: 16579997
    [Abstract] [Full Text] [Related]

  • 27. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S, Falbo A, Russo T, Orio F, Tollino A, Zullo F.
    Minerva Ginecol; 2008 Feb 22; 60(1):77-82. PubMed ID: 18277354
    [Abstract] [Full Text] [Related]

  • 28. Use of metformin in polycystic ovary syndrome: a meta-analysis.
    Creanga AA, Bradley HM, McCormick C, Witkop CT.
    Obstet Gynecol; 2008 Apr 22; 111(4):959-68. PubMed ID: 18378757
    [Abstract] [Full Text] [Related]

  • 29. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S, Rodien P, Rohmer V.
    Ann Endocrinol (Paris); 2002 Feb 22; 63(1):31-5. PubMed ID: 11937980
    [Abstract] [Full Text] [Related]

  • 30. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, Katsilambros N, Kreatsas G, Panidis D.
    Hum Reprod; 2006 Jun 22; 21(6):1426-31. PubMed ID: 16497699
    [Abstract] [Full Text] [Related]

  • 31. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S, Tok D, Caliskan M, Ozcimen EE, Gullu H, Uckuyu A, Erdogan D, Zeyneloglu H, Muderrisoglu H.
    Clin Endocrinol (Oxf); 2006 Jul 22; 65(1):75-80. PubMed ID: 16817823
    [Abstract] [Full Text] [Related]

  • 32. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep 22; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 33. Insulin-sensitizing agents in polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Eur J Endocrinol; 2006 Jun 22; 154(6):763-75. PubMed ID: 16728533
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, Annamaria C, Dale B, Zullo F.
    Hum Reprod; 2005 Oct 22; 20(10):2879-86. PubMed ID: 15958399
    [Abstract] [Full Text] [Related]

  • 36. [Polycystic ovary syndrome (PCOS)].
    Thaler CJ.
    MMW Fortschr Med; 2007 May 24; 149(21):33-5. PubMed ID: 17668731
    [Abstract] [Full Text] [Related]

  • 37. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
    Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, Dodson WC.
    Am J Obstet Gynecol; 2007 Apr 24; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436
    [Abstract] [Full Text] [Related]

  • 38. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
    Goldenberg N, Glueck C.
    Minerva Ginecol; 2008 Feb 24; 60(1):63-75. PubMed ID: 18277353
    [Abstract] [Full Text] [Related]

  • 39. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
    Cheang KI, Sharma ST, Nestler JE.
    Gynecol Endocrinol; 2006 Nov 24; 22(11):595-604. PubMed ID: 17145645
    [Abstract] [Full Text] [Related]

  • 40. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M.
    Akush Ginekol (Sofiia); 2005 Nov 24; 44(4):37-41. PubMed ID: 16028378
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.